SAR 43.0
(-0.12%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 23.04 Million SAR | 19.77% |
2022 | 19.24 Million SAR | 21.55% |
2021 | 15.83 Million SAR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 23.23 Million SAR | 0.8% |
2024 Q2 | 23.23 Million SAR | 0.0% |
2023 Q3 | 23.04 Million SAR | 3.53% |
2023 FY | 23.04 Million SAR | 19.77% |
2023 Q1 | 22.26 Million SAR | 15.69% |
2023 Q2 | 22.26 Million SAR | 0.0% |
2023 Q4 | 23.04 Million SAR | 0.0% |
2022 Q4 | 19.24 Million SAR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 138.49 Million SAR | 83.359% |
Al-Dawaa Medical Services Company | 3.39 Billion SAR | 99.321% |
Nahdi Medical Company | 2.9 Billion SAR | 99.208% |
Almujtama Alraida Medical Co. | 312.21 Million SAR | 92.618% |